We are strengthen our office in Lund with a new site manager
The management team at QAdvis is delighted to announce that Annelie Hagström has been appointed as ...
QAdvis News #2 – 2022
Artificial Intelligence / Machine Learning – and one of our consultants Cilla Lundevall. It is ...
QAdvis participate in Regulatory Summit 31, March
Meet our new CEO Emma Axelsson and listen to three of our consultants Cecilia Emanuelsson, Nils ...
Post-market clinical follow-up under MDR
Post-market clinical follow-up (PMCF) is an important requirement under the EU Medical Device ...
QAdvis News #1 – 2022
2022 has just started! We have several exciting news to share with you! 2022 has just started and ...
Publication of Regulation (EU) 2022/112
–A Risk based roll-out plan for certain In Vitro Diagnostic medical devices and In-house devices On ...
Clinical Trials Regulation (CTR) (Regulation EU No 536/2014)
The Clinical Trials Regulation (CTR; EU No 536/2014) will replace the EU Clinical Trial Directive ...
Welcome to QAdvis!
We are very pleased to welcome a new consultant, Nils Lidström to our QAdvis team! Nils has a ...
Initiative for Accelerating Clinical Trials in the EU (ACT EU)
The European Commission (EC), Heads of Medicines Agencies (HMA) and the European Medicines Agency ...